Zobrazeno 1 - 10
of 25
pro vyhledávání: '"William L. McGinnis"'
Autor:
James R. Jett, Sumithra J. Mandrekar, Steven E. Schild, William L. McGinnis, Yolanda I. Garces, Katie L. Allen, Richard L. Deming, P. J. Stella, Alex A. Adjei, Aminah Jatoi
Publikováno v:
Cancer. 110:363-368
BACKGROUND. The objective of this study was to assess the value of combined-modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c77cbc3ca9cb6694e5164664df3df33
https://doi.org/10.1002/cncr.22780
https://doi.org/10.1002/cncr.22780
Autor:
Tom R. Fitch, David L. Graham, Shauna Hillman, Paul L. Schaefer, Homayoon Shahidi, Donald W. Northfelt, Loren K. Tschetter, William L. McGinnis, Yolanda I. Garces, Steven E. Schild, Alex A. Adjei, James R. Jett
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 65:1106-1111
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of radiation that can be administered with carboplatin and paclitaxel. Methods and Materials: This trial included 15 patients with unresectable non–small-cell lung canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f253c1cbc7774ec099e9e422ca80a727
https://doi.org/10.1016/j.ijrobp.2006.02.046
https://doi.org/10.1016/j.ijrobp.2006.02.046
Autor:
Philip J. Stella, Aminah Jatoi, James A. Mailliard, Steven E. Schild, James E. Krook, James R. Jett, William L. McGinnis, Burke J. Brooks, James A. Bonner, Alex A. Adjei, Richard L. Deming, Sumithra J. Mandrekar
Publikováno v:
Cancer. 103:2349-2354
BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice-daily radiotherapy (BIDRT) or once-daily radiotherapy (QDRT) resulted in a better out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da7c698d1ed5d434d961409fba7fc764
https://doi.org/10.1002/cncr.21034
https://doi.org/10.1002/cncr.21034
Autor:
James R. Jett, William L. McGinnis, Steven E. Schild, John W. Kugler, Philip J. Stella, Steven P Goetz, Susan Geyer, Randolph S. Marks, Steven A. Kuross, James A. Mailliard, Paul L. Schaefer, James A. Bonner
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 54:370-378
Purpose: This Phase III study was performed to determine whether chemotherapy plus b.i.d. or q.d. radiotherapy (RT) resulted in superior survival for patients with Stage III non-small-cell lung cancer (NSCLC). Methods and Materials: Patients with Sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8471a212bc8e6c163fca1f73bda0358
https://doi.org/10.1016/s0360-3016(02)02930-9
https://doi.org/10.1016/s0360-3016(02)02930-9
Autor:
Christi A. Patten, P. J. Stella, William L. McGinnis, Susan Geyer, Randolph S. Marks, Jeff A. Sloan, James A. Bonner, Lisa Sanderson Cox
Publikováno v:
Psycho-Oncology. 11:472-478
There is limited research of smoking cessation following diagnosis of lung cancer. This prospective study assessed cigarette smoking behavior among 226 patients (142 males, 84 females) prior to, at the time of, and after the diagnosis of unresectable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d45ed1b602763f0b0598ae23f5213cd9
https://doi.org/10.1002/pon.612
https://doi.org/10.1002/pon.612
Autor:
Steven A. Kuross, John T. Cole, Terrence L. Cascino, James A. Mailliard, Roscoe F. Morton, Judith R. O'Fallon, William L. McGinnis, Preston D. Steen, Alan K. Hatfield, Jan C. Buckner, Paula J. Schomberg, Bernd W. Scheithauer, Albert M. Bernath
Publikováno v:
Cancer. 92:420-433
BACKGROUND The current study was conducted to determine whether the addition of interferon-α (IFN-α) to treatment with radiation therapy and carmustine (BCNU) improves time to disease progression or overall survival in patients with high-grade glio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0a3f07879c1a23222f55e2e34ff732f
https://doi.org/10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co
https://doi.org/10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co
Autor:
Robert P. Dinapoli, Jan C. Buckner, William L. McGinnis, Paul J. Novotny, Judith R. O'Fallon, Paula J. Schomberg, Evanthia Galanis, Roscoe F. Morton
Publikováno v:
Journal of Neurosurgery. 93:201-207
Object. It is standard practice for the oncological follow-up of patients with brain tumors (especially in the setting of clinical trials) to include neurological examination and neuroradiological studies such as computerized tomography (CT) or magne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de61b23b08e9d2e892e7c59b5f9f5d6a
https://doi.org/10.3171/jns.2000.93.2.0201
https://doi.org/10.3171/jns.2000.93.2.0201
Autor:
Robert F. Marschke, William L. McGinnis, Rajender K. Ahuja, Edward G. Shaw, Edward T. Creagan, Patricia A. Johnson, Phillip J. Stella, James A. Mailliard, Jeff A. Sloan, James A. Bonner
Publikováno v:
Cancer. 82:1037-1048
BACKGROUND A three-arm Phase III randomized trial was performed to compare response rates, time to local or distant progression, and survival for patients with unresectable (Stage IIIA or IIIB) nonsmall cell lung carcinoma treated with standard fract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f17efb7476c44c5e17aa5680ce234d4
https://doi.org/10.1002/(sici)1097-0142(19980315)82:6<1037::aid-cncr5>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19980315)82:6<1037::aid-cncr5>3.0.co
Autor:
S L Humphrey, R.G. Drummond, Randy L. Moore, Steven J. Buskirk, Thomas G. Shanahan, Jeff A. Sloan, William L. McGinnis, Steven E. Schild, Albert R. Frank, S. P. Kahanic, Charles L. Loprinzi
Publikováno v:
Journal of Clinical Oncology. 15:1239-1243
PURPOSE To determine whether a sucralfate oral solution can prevent/alleviate radiation-induced esophagitis. PATIENTS AND METHODS Patients included on this clinical trial were beginning thoracic radiation therapy to the mediastinum. Following stratif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8f5f33e7500a06118c90b5782a7ce3
https://doi.org/10.1200/jco.1997.15.3.1239
https://doi.org/10.1200/jco.1997.15.3.1239
Autor:
Steven E, Schild, Philip J, Stella, Susan M, Geyer, James A, Bonner, Randolph S, Marks, William L, McGinnis, Steven P, Goetz, Steven A, Kuross, James A, Mailliard, John W, Kugler, Paul L, Schaefer, James R, Jett
Publikováno v:
International journal of radiation oncology, biology, physics. 54(2)
This Phase III study was performed to determine whether chemotherapy plus b.i.d. or q.d. radiotherapy (RT) resulted in superior survival for patients with Stage III non-small-cell lung cancer (NSCLC).Patients with Stage III NSCLC and an Eastern Coope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8959a065adfedda0c7db23b6e62ad0b
https://pubmed.ncbi.nlm.nih.gov/12654462
https://pubmed.ncbi.nlm.nih.gov/12654462